Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

And Now, For Some More Pharma Layoffs…
Pharmalot
Tuesday, January 29, 2013 - 10:28am
tags:
layoffs
Allergan wins round in patent fight over Lumigan
Reuters
Tuesday, January 29, 2013 - 10:27am
tags:
Allergan, patents, Lumigan, Teva, Sandoz, glaucoma
Generic Launch at Dr. Reddy's
Yahoo/Zacks
Tuesday, January 29, 2013 - 10:25am
tags:
generics, Dr Reddy's, Merck, Clarinex
Bristol-Myers Squibb's Dividend Increase And Promising New Drugs
Seeking Alpha
Tuesday, January 29, 2013 - 10:23am
tags:
dividend, Bristol-Myers Squibb, Eliquis, Yervoy, PDL-1, Abilify, Forixga
Should Johnson & Johnson Break Up?
Motley Fool
Tuesday, January 29, 2013 - 10:21am
tags:
JNJ
Illumina Beats on Both Top and Bottom Lines
Motley Fool
Tuesday, January 29, 2013 - 9:26am
tags:
Illumina, earnings
Eli Lilly has no plans to shed its Elanco animal health unit
The Fly on the Wall
Tuesday, January 29, 2013 - 9:25am
tags:
Eli Lilly, Elanco, animal health
Redhill Seeks Migraine, Oncology Partners After Nasdaq Listing
Bloomberg
Tuesday, January 29, 2013 - 9:24am
tags:
migraines, oncology, Redhill Biopharma
Lilly Profit Beats Analyst Estimates as Cymbalta Sales Climb
Bloomberg
Tuesday, January 29, 2013 - 9:22am
tags:
earnings, Eli Lilly
Pfizer Q4 results top forecast, gives cautious 2013 view
Reuters
Tuesday, January 29, 2013 - 9:12am
tags:
Pfizer, earnings
Biosensors lands CE Mark for BioFreedom polymer-free stent
Mass Device
Monday, January 28, 2013 - 10:35pm
tags:
Biosensors International Group, CE Mark, stent
Hypertension: ReCor Medical lands Euro win for ultrasound-based renal denervation
Mass Device
Monday, January 28, 2013 - 10:34pm
tags:
ReCor Medical, hypertension, European, ultrasound, renal denervation, devices
Direct Flow lands Euro win for TAVI system
Mass Device
Monday, January 28, 2013 - 10:33pm
tags:
European, EU, TAVI, regulatory, devices
Biosensors International fires latest round in EU stent battle
FierceMedicalDevice
Monday, January 28, 2013 - 10:27pm
tags:
Biosensors International Group, EU, Europe, stent, devices
More and more companies forcing customers to pay device tax
FierceMedicalDevice
Monday, January 28, 2013 - 10:27pm
tags:
device tax, devices
Bausch + Lomb grabs German ophthalmology laser company
FierceMedicalDevice
Monday, January 28, 2013 - 10:26pm
tags:
ophthalmology, M&A, laser, Germany, devices, Bausch & Lomb
Medtronic Initiates Landmark Study of Neurostimulation Therapy for Failed Back Surgery Syndrome
Yahoo/Reuters
Monday, January 28, 2013 - 10:18pm
tags:
Medtronic, research, neurostimulation, therapy, innovation, surgical, devices
Faruqi & Faruqi, LLP Launches An Investigation Against Sirona Dental Systems Inc. (SIRO) For Potential Violations Of State Laws By Its Directors
Yahoo/BusinessWire
Monday, January 28, 2013 - 10:17pm
tags:
investigation, legal, Sirona Dental, devices
Varian Receives FDA Clearance
Yahoo/Zacks
Monday, January 28, 2013 - 10:16pm
tags:
Varian, FDA, regulatory, radiosurgery, devices
Vision-Sciences Reports Net Sales of $4.0 Million for Third Quarter of Fiscal 2013
Yahoo/GlobeNewswire
Monday, January 28, 2013 - 10:16pm
tags:
Vision-Sciences, earnings, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.